• Like


Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Hematology and Oncology



  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads


Total Views
On SlideShare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. H e m ato l o g y a n d O n c o l o g y A f o c u s o n P ro s tat e Ca n c e r 2009 annual report
  • 2. Introduction Randy Hurley, M.D. Chairperson Cancer Program Dear Friend, I am excited to present this year’s HealthPartners and Regions Hospital Hematology and Oncology Annual Report. We are an American College of Surgeons certified comprehensive community cancer center with an emphasis on patient care and a strong focus on education and clinical research. From a patient care standpoint, we leverage the membership in our non-profit integrated health care system to improve the care we give our patients. We coordinate multidisciplinary cancer care through the use of an electronic medical record. We empower patients with tools to make informed choices including our online services, the Lundborg Patient Library and additional programs. We use standardized treatment algorithms based on national consensus guidelines to ensure all patients, including the underserved, receive the best treatment available. Finally, we measure outcomes and compare ourselves with national benchmarks to ensure quality cancer care delivery. In this issue we highlight our multidisciplinary approach to early-stage prostate cancer. Prostate cancer is the most common cancer affecting men. The incidence of prostate cancer in men is higher than the incidence of breast cancer in women. Just as women have choices for the treatment of early-stage breast cancer, men also have choices for the treatment of early stage prostate cancer. Inside, we describe our shared decision making program and treatment options for men with early-stage disease. Lastly, I take pride in “showing off” our new in-patient cancer unit. With the Regions 2009 expansion, we now have a new state-of-the-art in-patient facility for patients requiring hospitalization for their cancer care at Regions Hospital. Once again, we appreciate the privilege of serving you and your patients. Please feel free to contact me if you have any questions about our program or have suggestions on ways we can improve the care we deliver. Randy Hurley, M.D. Medical Director, HealthPartners/Regions Hematology and Cancer Care Program randy.w.hurley@healthpartners.com Assistant Professor of Medicine Division of Hematology, Oncology and Transplantation University of Minnesota 2 hematology and oncology
  • 3. program news Regions Expansion 2009 This was an exciting year for Regions Hospital. We opened the new section of the hospital which includes a new main entrance, private patient rooms, emergency center, 20 operating rooms and a 450-space underground parking ramp. As part of our expansion, patients needing inpatient care for their oncology treatments are now located in our new 6 South Section. This unit incorporates staff from three existing units into one central Our hematology and oncology patients are area. Nursing care is given to patients with differing requirements now located in new private patient rooms. including general medical 2009 Regions Hospital expansion care, intermediate care and intensive care. Physicians who includes new inpatient oncology unit. direct the care of the patient unit include Regions hospitalists, intensivists, oncologists and other specialists as needed. The 6 South Section includes 36 private patient rooms, each with their own bathroom. The new patient rooms were designed to accommodate differing care needs including rooms to suit special needs related to isolation. The patient rooms are large and include abundant natural light and spectacular views of downtown St. Paul. Each room has been designed to support our goal of being a patient/family centered hospital. Each room has a provider zone, patient zone and family zone. The provider space allows the caregiver staff, including nurses, closer access to the patient. Besides family space in the room, there are separate areas on the unit for private conferences as well as open areas for waiting. Our new unit brings our whole team together in a centralized location and allows us to be closer to the patient and family. Lundborg Library nears 10-year milestone The Patricia D. Lundborg Cancer Library at Regions Hospital offers cancer resources in a convenient, on-site facility. The library, created in 2000, is staffed by a librarian and provides resources for patients, their families and friends, hospital staff and members of the community. Annual library usage has continued to increase each year. The Library enters its 10th year of existence in 2010. A continuum of care through palliative care and hospice HealthPartners Cancer Care Centers partner with HealthPartners Hospice and the Regions Hospital Palliative Care Team to provide a continuum of care that enhances end of life care. Multidisciplinary team meetings are held weekly and include representatives from medical oncology, nursing, inpatient and outpatient social work, health psychology, HealthPartners hospice and palliative care team members. Through this partnership, care is coordinated from the hospital to the clinic to the patient’s home. 2009 annual report 3
  • 4. people Program News Kurt Survivorship Program enters second year Demel, MD, is the medical The HealthPartners and Regions Cancer Survivorship Program, under the direction director of the of Dr. Kurt Demel, is entering its second year of providing comprehensive survivorship survivorship care plans to cancer patients. The success of the program has led to an program invitation to participate in the Excellence in Survivorship care meeting. Sponsored and recently completed his by the Livestrong Survivorship Center of Excellence, this program is designed to MBA. foster and improve cancer survivorship care. Cancer Survivors Advisory Council Colleen Morton, MD, The HealthPartners Cancer Survivors Advisory Council is a forum for patients who manages the hemostasis and have completed their acute cancer treatment at Regions Hospital and Riverside Cancer thrombosis Care Centers and who are now transitioning into long-term cancer management. program. She has interest in thrombotic Members of the council are asked to share their experiences and to contribute disorders of pregnancy and is ideas on how HealthPartners can improve the treatment and support of cancer working with the U of M to survivors. The twelve-member council met seven times in 2009 and was asked to develop city-wide protocols make recommendations on services already offered and to assist with the design of to standardize treatment of bleeding and clotting new services. The first topic presented to the council was patient education materials. disorders. Feedback from the council guided the changes we made. Educational materials are now easier to understand and more specific to the needs of the patient. The experiences and recommendations of the advisory council were also an integral Gretchen part of the development of two new programs that began in late 2009. “Let’s Get Ibele, MD, treats adult Physical” is a beginner-level physical activity class tailored to the needs of cancer patients with patients who want to improve their level of physical conditioning. “Renewing Life” oncologic and is a transformative program of education and support that engages participants in hematologic diseases and an exploration of the possibilities for growth in living with serious illness. Both of was named to these programs are lead by cancer survivors and are available at a minimal cost. the Minnesota Monthly Top Doctors for Women 2009 list. Our hematology and oncology program utilizes a Cancer Survivors Advisory Council to help us make recommendations on new and existing patient services. Back row: Scott Cruse, Marge Watry, Ron Bentley, Carolyn Markwood Nyberg, Churon Webb, Micky Gutzmann, Gobind Tarchand, Marjorie Moore Dan Front row: Deanna McWilliam, Joe Kennedy, Judy Clasen Schneider, MD, had the highest patient-rated satisfaction of over 220 specialty physicians in the HealthPartners system. 4 hematology and oncology
  • 5. Education people Jeff Jaffe, MD, practices Training tomorrow’s hematologist/oncologists — medical HealthPartners’ partnership with the University of Minnesota oncology and hematology Division of Hematology, Oncology and Transplantation with interests Fellowship program in breast cancer and Regions Hospital is a clinical training site for the University of Minnesota hematologic Hematology/Oncology Fellowship program and is regarded as one of the highest malignancies. He is also the Regions site director ranked rotations by University Fellows. Dr. Jeff Jaffe heads the teaching program for Hematology/Oncology at Regions Hospital which combines clinical experience with specific teaching educational programs for conferences. With over 20 years of teaching experience, Dr. Jaffe and other the University of Minnesota Medical School. HealthPartners oncologists have mentored many of the oncologists that practice in the Twin Cities area. This year, three HealthPartners oncologists were nominated for a teaching award among teaching faculty at the University of Minnesota, Veterans Administration Hospital and Hennepin County Medical Center. Balkrishna Dr. Balkrishna Jahagirdar won the award for outstanding clinical mentorship. Jahagirdar, MD, received Regions hematology and oncology faculty provide elective rotations for the the 2009 University of Minnesota internal medicine residents and teach in the Medical School Outstanding second year hematology course for medical students. Faculty also coordinate six Clinical Teacher hours of hematology and oncology lectures in the University’s Global Health course. award from the University of Minnesota Hematology Oncology Fellowship Program. HealthPartners hosts Oncology Nursing Symposium In April 2009, HealthPartners hosted an Oncology Nursing Symposium. This half- Scott Cruse, day event was certified for continuing education credit by the Oncology Nursing Lead Society and was attended by over 60 nurses and health care professionals from the Oncology Twin Cities area and western Wisconsin. A wide range of topics were discussed Social including oncologic emergencies, survivorship and new trends in cancer clinical Worker, has interest trials. We look forward to a second symposium in April 2010. in working with patients going through Regions Breast Health Center partners with University of the trauma of cancer, facilitating patient support groups and Minnesota to develop breast radiology fellowship developing programs and services for patients. The Regions Hospital Breast Health Center partnered with the University of Minnesota, Saint Paul Radiology and four radiology practices in the Twin Cities to develop a Breast Imaging Fellowship program to train two board certified radiologists each year in the radiology subspecialty of breast imaging. This unique Joe Tashjian, MD, is the program has the advantage of combining the comprehensive research program in coordinator breast imaging at the University of Minnesota with the excellent clinical practices of the breast that are present at community centers, including the Regions Hospital Breast Health radiology fellowship Center. The partnership will allow the program to attract highly qualified and program motivated individuals into the arena of breast imaging and will increase the number and is a of dedicated breast imagers to serve our community in the future. radiologist with St. Paul Radiology who specializes in chest and breast imaging and diagnosis. 2009 annual report 5
  • 6. people Research Daniel Anderson, Minnesota CGOP and Minnesota CCOP to merge MD, is the Dr. Dan Anderson of HealthPartners and Regions Hospital is the director of the principal Minnesota Cooperative Group Outreach Program (CGOP). The CGOP provides investigator and director access to over 80 National Cancer Institute-sponsored clinical trials for patients for the with cancer. HealthPartners provides the largest number of additions to clinical Minnesota Cooperative Group trials in this program. Plans are underway to merge CGOP with the Minnesota Outreach Program. Community Cancer Oncology Program (CCOP) and develop an even larger consortium with expanded access to clinical trials. Cheri Rolnick, Cancer Research Network celebrates 10th year PhD, MPH, is the Ten years ago, HealthPartners Research Foundation (HPRF) became a associate participating organization of the Cancer Research Network (CRN). The CRN is a director of research for consortium of 14 non-profit research centers that collectively provide care to over the HPRF 11 million individuals across the United States. Through the CRN connection, and a member of the Cancer HealthPartners has also been involved with the Minnesota Cancer Alliance Research Network. She will (MCA), a consortium developed to implement Minnesota’s Comprehensive take over as the Chair of the Minnesota Cancer Alliance Cancer Control Plan. Steering committee in 2010. Colorectal cancer Survivor Care Plan in development Kathy HealthPartners Research Foundation, in collaboration with the Minnesota Cancer Fuhrmann, Alliance, has received a grant from the American Cancer Society to develop a MS, Certified Survivorship Care Plan specifically for colorectal cancer. This two-year research Genetic Counselor, project will involve obtaining input from health care providers and survivors across provides Minnesota on elements they would like to see incorporated into a care plan. genetic counseling services for the Cancer Care Center for individuals with Pilot project examines text messaging to promote healthy a personal history of cancer behaviors among adolescent cancer survivors or a strong family history of cancers. Dr. Emily Parker, a researcher at HealthPartners Research Foundation, is conducting a pilot study using text messaging to test weight gain prevention in adolescent survivors of childhood cancers. Due to late effects of treatment and disease, survivors of childhood cancers are at increased risk of unhealthy weight gain, obesity and cardiometabolic disease. Innovative methods of intervention are needed to address the increased risk of obesity in young cancer survivors. Data collection on breast cancer in older women continues Feifei Wei, PhD, is the HealthPartners principal investigator on a continuation study of long-term (5-year) survivors of breast cancer of those 65 and older. The study aims to understand and reduce the adverse effects of cancer treatment in older adults. Additional information will be collected about this breast cancer cohort through monitoring that will continue for 15 years following treatment. 6 hematology and oncology
  • 7. A Focus on Prostate Cancer people Parker Focus on prostate cancer Eberwein, MD, is the Prostate cancer is the most common cancer among American men. Nearly one in Chair of Urology six men will develop prostate cancer in their lifetime. The incidence is highest and Director in African American men and lowest in Asians and Native Americans. In 2009, of Robotic 192,000 new cases of prostate cancer will be diagnosed. With the advent of the Surgery for Regions prostate specific antigen (PSA) blood test, more and more men are being diagnosed Hospital and HealthPartners. at an earlier stage when cancer is still localized to the prostate gland. His interests are minimally invasive surgical techniques, endourology and cryotherapy treatment of urologic HealthPartners and Regions Hospital prostate malignancies. cancer program HealthPartners and Regions Hospital treated 92 new cases of prostate cancer in Mark 2008 compared to just 39 cases in 2003. This increase is in no small part due to Bisignani, the development of a dedicated multidisciplinary prostate cancer team. Ninety MD, is the medical percent of the cancers in 2008 were diagnosed at an early stage of disease. To director of facilitate multidisciplinary treatment planning for patients with urologic cancers, the Regions we participate in specialized Urologic Tumor Conferences and Family Tumor Radiation Conferences. Therapy Program and has expertise with intensity modulated The Surveillance, Epidemiology and End Result (SEER) Program of the National and image guided radiation Cancer Institute reports 5-year relative survival rates for prostate cancers diagnosed therapy. between 1999 and 2005. Relative survival rates compare survival of cancer patients with those of the general population to estimate the effect of cancer. The SEER database reports a relative survival rate of 100 percent for localized (stage 1 and Cesar Ercole, MD, 2) and regional (stage 3) prostate cancer and a 30 percent 5-year relative survival has clinical rate for advanced stage 4 disease. The Regions Hospital Cancer Registry reports interest in overall survival rates which includes death due to unrelated causes. Therefore, it urologic is not directly comparable to SEER data. The Regions Hospital Cancer Registry oncology, prostate data reports an 84 percent 5-year overall survival rate for localized disease, a 100 disease and percent 5-year survival rate for regional stage 3 disease and a 20 percent 5-year general urology. overall survival rate for advanced stage 4 disease. The Regions prostate cancer 5-year survival (2003-2008) can also be compared to American Joint Committee on Cancer (AJCC) staging using National Cancer Data Base (NCDB) statistics. Because of methodology, none of the Regions cases are stage 1. However, the 5-year survival for stage 2, 3 and 4 prostate cancers at Regions Hospital is 85, 100 and 36 percent. This compares to the NCDB 5-year survival of 88, 89 and 37 percent for stage 2, 3 and 4 prostate cancers respectively. Diana Christensen Johnston Prostate cancer is the most common cancer and Carol Jirik are Oncology Certified Nurses among American men. Nearly one in six men that supervise the Regions and Riverside Cancer Care will develop prostate cancer in their lifetime. Centers. Together they have over 50 years of oncology experience. 2009 annual report 7
  • 8. A Focus on Prostate Cancer Multidisciplinary planning and shared decision in the treatment of early-stage prostate cancer Early-stage prostate cancer is localized prostate cancer that has not spread beyond the prostate. Men with newly diagnosed early-stage prostate cancer often have several treatment options available to them. This may include surgery, radiation therapy, watchful waiting, and in some instances, cryosurgery. Multidisciplinary treatment planning involves a team of specialists including a urologic surgeon, radiation oncologist, and occasionally a medical oncologist. We offer patients and their families a shared decision-making experience allowing patients to participate fully in decisions regarding their care. Treatment options for localized prostate cancer Robotic Prostatectomy at Regions Hospital Robotic-assisted laparoscopic prostatectomy is a form of minimally invasive prostate surgery performed by Dr. Parker Eberwein and Dr. Cesar Ercole. Robotic prostatectomy may be a treatment option for patients with localized prostate cancer. Compared to a traditional open radical retropubic prostatectomy, advantages* for patients include a faster recovery time, shorter hospital stay, and potentially reduced bleeding and less urinary and erectile dysfunction. Cryosurgery for the treatment of localized prostate cancer Cryosurgery is the use of extremely cold temperatures to freeze prostate tumors and kill cancer cells. During an outpatient procedure, several small needle-like cryoprobes are inserted into the prostate gland under ultrasound guidance. Argon gas is then circulated through these probes during controlled freezing of the prostate gland. Short term PSA-relapse-free survival is comparable to da Vinci Surgical radiation therapy with acceptable health-related quality System robot of life-based outcomes. The American Urological Association’s 2008 Best Practices Policy Statement on prostate cryosurgery indicates that in selected patients, prostate cryosurgery may be an option for the treatment of early stage disease. Cryosurgery has also been used effectively to treat recurrent prostate cancer after radiation therapy. *As with any surgical procedure these benefits cannot be guaranteed as surgery is both patient-specific and procedure specific. 8 hematology and oncology
  • 9. A Focus on Prostate Cancer Regions Hospital has been designated as an International Center of Excellence for Cryotherapy. Treatment efforts are being led by Dr. Parker Eberwein who has over a decade of experience with this technique. Intensity-Modulated Radiation Therapy Radiation therapy (RT) and radical prostatectomy are treatment options with the longest follow-up for patients with localized prostate cancer. Long-term outcomes are similar. The goal of RT for men with localized prostate cancer is the delivery of a therapeutic dose of radiation to the prostate gland Cryosurgery while minimizing the dose to normal surrounding tissues. The treatment device prostate gland lies in close proximity to the rectum and bladder. Avoidance of these structures decreases the risk of long-term side effects. In recent years, new conformal techniques have been developed which allow the delivery of higher doses to the prostate and better spare surrounding tissues. Intensity modulated radiation therapy (IMRT) is a technique which enables the radiation dose to be ‘sculpted’ around the prostate gland. Gold seed markers are usually placed in the prostate gland prior to a course of radiation therapy. This is helpful in localizing the gland (image-guided radiation therapy) since the prostate can shift a small degree from day to day. In general, treatment is very well tolerated. There can be a few minor urinary symptoms such as urgency or frequency during radiation. Treatments typically take 15-20 minutes each day over an eight and a half week period of time. Following radiation therapy, response is monitored by observing the (PSA) level, which is a simple blood test. Both intensity-modulated and image-guided radiation therapy are available at the Regions Radiation Therapy Center. Radiation therapy is an option for prostate cancer treatment. 2009 annual report 9
  • 10. Ca n c e r R e g i s t ry 2 0 0 8 Since 1984, our Cancer Registry has accumulated over 17,000 cancer cases and is actively following more than 5,700 patients The main goal of the Cancer Registry is to serve as a primary source of cancer information for cancer care professionals. The Cancer Registry contains a wealth of valuable data, including demographics, histology and staging, treatment modalities and clinical outcomes. Our registrars also spend time on follow-up of these cases, resulting in a 93 percent follow-up rate. The Registry is also responsible for scheduling weekly cancer conferences. A significant number of our cancer patients have their diagnosis and treatment discussed weekly by a multidisciplinary group of cancer care professionals. The American College of Surgeons requires that managing physicians be responsible for documenting accurate staging of cancer. Our Cancer Registry has a 98 percent accuracy rate for cancer staging. Sue Braaten and Margo Hess To request registry data, please contact our registry Regions Hospital cancer registrars team at: 651-254-2821 Regions Hospital Cancer Registry 2008 Total Cases in the Cancer Registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,081 (Since January 1, 1984.) Total Actively Followed Cases in the Cancer Registry in 2008 . . . . . . . . . . . . . . 5,708 New Cases in 2008 New Analytic Cases in 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,103 (Cases initially diagnosed and/or treated at Regions Hospital.) New Non-analytic Cases in 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 (Cases that receive subsequent treatment/care at Regions Hospital following initial diagnosis and treatment at another facility.) Total New Cases in 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,160 10 hematology and oncology
  • 11. Cancer Diagnosis and Care Trends in cancer diagnosis at Regions Hospital A review of the five-year trends shows an increase in the number of prostate cancer cases. This likely reflects an increased role of Regions as a referral center and the increased use of our multidisciplinary prostate cancer approach. LEUKEMIA/ GYNECOLOGIC BREAST LUNG COLORECTAL (excluding IN II)* PROSTATE HEAD & NECK MELANOMA LYMPHOMA 300 288 280 270 270 249 240 210 202 180 150 145 137 131 120 123 111 114 107 102 90 93 92 81 75 77 90 71 67 60 60 48 50 49 44 39 37 38 38 36 35 36 30 31 33 26 28 28 25 13 0 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 Major Cancer Sites — 2008, Regions Hospital Male Female SITE PERCENT SITE PERCENT Lung 19% Breast 43% Leukemia/Lymphoma 17% Lung 15% All others 16% Leukemia/Lymphoma 10% Prostate 9% All others 9% Urinary 9% Colorectal 6% Colorectal 8% Brain 4% Melanoma 7% Urinary 4% Head and Neck 6% Melanoma 3% Brain 3% Gynecologic (excluding CIN III)* 2% Pancreas 3% Head and Neck 2% Breast 2% Pancreas 1% Stomach/Small Bowel 1% Stomach/Small Bowel 1% *Excluding cervical intraepithelial neoplasia (CIN) III, and benign and borderline malignancies 2009 annual report 11
  • 12. P ro f e s s i o n a l a n d C o m m u n i t y I n vo lv e m e n t Professional Organizations & Certifications Alpha Omega Alpha American Association of Medical Dosimetrists American Association of Physicists in Medicine: AAPM - local chapter president American Association of Physicists in Medicine: faculty member and presenter American Association of Physicists in Medicine: local chapter secretary American College of Surgeons American Freestanding Radiation Oncology Centers American Medical Association American Registry of Radiologic Technologists American Society of Clinical Oncology THIS PORTION CUT OFF American Society of Hematology American Society of Radiologic Technologists American Society of Therapeutic Radiology and Oncology American society of Tropical Medicine and Hygiene Association of Community Cancer Centers Minnesota Cancer Alliance Minnesota Society of Clinical Oncology Oncology Nursing Society Society for Surgery of the Alimentary Tract State Advisory Board for Radiation and Radioactive Material Wilderness Medical Society Local Community Service Big Brother Big Sister Volunteer Firefighter The Breast Cancer 3-Day event Local Women’s Shelter Volunteers, Twin Cities Marathon including President of the Board Habitat for Humanity American Red Cross Animal Humane Society People and Experience Ambassador League of Women Voters MS/150 Bike Ride Classroom and Youth Groups Volunteers Relay for Life Participants and Volunteers Girl and Boy Scouts Al-a Non Sunday School Teachers Hearing Loss Association of America Local Food Shelves Individual Accomplishments Greta Anderson, unit support secretary, completed Cheryl Moulton, RN, participated in the Breast the Breast Cancer 3-Day event Cancer 3-Day with her daughter RNs Wendy Ness, Heidi Madison, Mary Srb Stacey Schuette and Donnie Price, RN, and Kathy Heitzinger attended 2-day oncology Race for the Cure participants conference at Mayo Clinic Leigh Strassman, Breast Cancer 3-Day volunteer Kari Richter, RN, completed the Relay for Life of Jessica Appert, Big Brothers and Sisters and White Bear Lake United Way volunteer Heather Peterson, RN, completed and was team Mark Towsley, Boy Scout leader and MN captain for Relay for Life of Woodbury Department of Health Advisory Committee C81 staff supported cancer survivor and her member children with holiday giving Regions Cancer Care Center staff supported a Sheryl Bendickson, RN, was mission chair for the patient and her children with holiday giving White Bear Lake area American Cancer Society and captain of We Care Walkers for the Relay for Life for White Bear Lake 2009 annual report
  • 13. Publications Tan, WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, Niedringhaus R, Bernath AM, Gamini SS, Palmieri F, Perez EA. (2009). Phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a north central cancer treatment group (ncctg) trial. Breast Cancer Res Treat, 106(1), 71-72. Glasser L, Meloni-Ehrig A, Greaves W, Demel KC, Butera J. (2009). Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation. Transfusion, 49(3), 555-562. Hussein K, Jahagirdar B, Gupta P, Burns L, Larsen K, Weisdorf D. (2008). Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia. Am J Hematol, 83(6), 446-50. Tuttle, TM Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA. (2009). Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol, 27(9), 1362-1367. Williams B, Morton C. (2008). Cerebral vascular accident in a patient with reactive thrombocytosis: a rare cause of stroke. Am J Med Sci. 336(3), 279-81. Coleman LA, Kottke TE, Rank B, Reding DJ, Selna M, Isham GJ, Nelson AF, Greenlee RT. (2008). Partnering care delivery and research to optimize health. Clin Med Res, 6(3-4), 113-118. Rank B. (2008). Executive physicals — bad medicine on three counts. N Engl J Med. 359(14), 1424-5. Jackson, J, Rolnick SJ. (2009). Knowledge, attitudes and preferences regarding advance directives among patients of a managed care organization. Am J Man Care, 15(3), 177-186. THIS PORTION CUT OFF McClure, JB, Divine G, Alexander G, Tolsma D, Rolnick SJ, Stopponi M, et al. (2009). A Comparison of smokers’ and nonsmokers’ fruit and vegetable intake and relevant psychosocial factors. Behav Med, 35(1), 14-22. Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL, Fletcher SW, Emmons KM, Geiger AM. (2008). Positive, negative, and disparate: women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 14(1), 25-32. Altschuler, A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL, Fletcher SW, Emmons KM, Geiger AM. (2009). Positive, negative, and disparate--women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J, 14(1), 25-32. Rolnick SJ, Jackson JM, Amundson JH. (2009). Development, Implementation and Evaluation of an Electronic Medical Record Prompt for Bone Density Testing. Health Informatics Journal, [At press]. Stopponi, MA, Ritzwoller DP, Alexander GL, Carroll NM, McClure JB, Divine GW, Calvi JH, Rolnick SJ, Johnson CC. (2009). Recruitment to a web-based nutritional intervention trial. J Med Internet Research, 11, 1-11. Rolnick, SJ, Calvi J, Heimendinger J, McClure JB, Kelley M, Johnson CC, Alexander GL. (2009). Focus groups inform a web-based program to increase fruit and vegetable intake. Pat Ed and Couns, 7(2), 314-318. Sukhanova A, Ritzwoller DP, Rolnick SJ, Calvi JH, McClure J, Alexander G, Johnson CC. (2009). Focus groups inform a web-based program to increase fruit and vegetable intake. Patient Educ Couns, 77(2), 314-318. hematology and oncology
  • 14. H e m ato l o g y a n d O n c o l o g y A f o c u s o n P ro s tat e Ca n c e r 2009 annual report Hematologists/Oncologists Multidisciplinary Team Dan Anderson, MD Specialized Surgical Oncologists Pharmacists Kurt Demel, MD Radiation Oncologists and Certified Medical Assistants Randy Hurley, MD Therapists Home Care & Hospice Gretchen Ibele, MD Oncology Certified Nurses Caregivers Jeffrry Jaffe, MD Clinical Laboratory Technicians Dietitians Bal Jahagirdar, MD Pathologists Chaplains Colleen Morton, MD Pain Management Providers Cancer Registrars Brian Rank, MD Genetics Counselor Ambulatory Coordinators Daniel Schneider, MD Social Workers Medical Office Assistants Psychotherapist Physician Hotline Multidisciplinary Team Online 651-254-3505 952-967-7616 regionshospital.com/cancer (for physician questions/consultations only) healthpartners.com/cancer 640 Jackson Street 2220 Riverside Avenue South St. Paul, MN 55101 Minneapolis, MN 55454 651-254-3572 612-349-8374